Clinical Trial Update: Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours [Phase 1]

View source ↗

Summary

A Phase I trial completed evaluating the effect of food on the pharmacokinetics of AZD1775 in patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AZD1775 (Adavosertib)

Snippet

Sponsor: AstraZeneca | Conditions: Solid Tumours | Phase 1 | Status: COMPLETED